CA Stock MarketDetailed Quotes

AGN Algernon Pharmaceuticals Inc

Watchlist
  • 0.130
  • +0.015+13.04%
15min DelayMarket Closed Jul 12 15:29 ET
2.84MMarket Cap-619P/E (TTM)

Algernon Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
(Q3)May 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.52%1M
-72.24%521.97K
-12.92%5.24M
-54.80%985.85K
40.80%1.13M
-32.06%1.25M
56.56%1.88M
-25.23%6.02M
299.45%2.18M
-52.21%801.17K
Selling and administrative expenses
-42.54%665.2K
-76.75%354.4K
11.28%4.15M
-41.64%797.49K
-6.51%667.45K
8.02%1.16M
165.39%1.52M
14.52%3.73M
81.40%1.37M
11.80%713.93K
-Selling and marketing expense
-86.89%40.55K
-81.87%104.86K
72.75%1.26M
-35.93%217.7K
26.41%155.55K
148.79%309.16K
305.26%578.3K
-8.12%729.8K
44.64%339.78K
-31.88%123.05K
-General and administrative expense
-26.39%624.65K
-73.62%249.54K
-3.69%2.89M
-43.53%579.79K
-13.37%511.91K
-10.44%848.58K
119.15%945.86K
21.83%3M
98.06%1.03M
29.03%590.88K
Research and development costs
276.45%339.01K
-52.95%167.58K
-52.25%1.1M
-76.88%188.36K
427.98%460.58K
-88.22%90.06K
-43.17%356.17K
-52.19%2.29M
493.11%814.69K
-91.59%87.23K
Operating profit
19.52%-1M
72.24%-521.97K
12.92%-5.24M
54.80%-985.85K
-40.80%-1.13M
32.06%-1.25M
-56.56%-1.88M
25.23%-6.02M
-299.45%-2.18M
52.21%-801.17K
Net non-operating interest income (expenses)
0.00%308
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
-36.77%294
-82.58%2.08K
-28.83%464
-75.79%550
Non-operating interest income
0.00%308
42.86%420
0.91%2.1K
64.01%761
33.45%734
-48.58%308
-36.77%294
-82.58%2.08K
-28.83%464
-75.79%550
Other net income (expenses)
-4,125.19%-1.54M
-111.96%-36.48K
Special income (charges)
----
----
-4,125.19%-1.54M
----
----
----
----
---36.48K
----
----
-Less:Impairment of capital assets
----
----
4,125.19%1.54M
----
----
----
----
--36.48K
----
----
Income before tax
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
Income tax
Earnings from equity interest net of tax
Net income
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
Net income continuous operations
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
Noncontrolling interests
Net income attributable to the company
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
52.17%-800.62K
Diluted earnings per share
61.54%-0.05
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
-32.62%-0.2
16.43%-0.87
-4,514.89%-0.29
43.28%-0.12
Basic earnings per share
61.54%-0.05
85.00%-0.03
48.28%-0.45
44.78%-0.1601
16.67%-0.1
51.85%-0.13
-32.62%-0.2
16.43%-0.87
-4,514.89%-0.29
43.28%-0.12
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022(Q3)May 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.52%1M-72.24%521.97K-12.92%5.24M-54.80%985.85K40.80%1.13M-32.06%1.25M56.56%1.88M-25.23%6.02M299.45%2.18M-52.21%801.17K
Selling and administrative expenses -42.54%665.2K-76.75%354.4K11.28%4.15M-41.64%797.49K-6.51%667.45K8.02%1.16M165.39%1.52M14.52%3.73M81.40%1.37M11.80%713.93K
-Selling and marketing expense -86.89%40.55K-81.87%104.86K72.75%1.26M-35.93%217.7K26.41%155.55K148.79%309.16K305.26%578.3K-8.12%729.8K44.64%339.78K-31.88%123.05K
-General and administrative expense -26.39%624.65K-73.62%249.54K-3.69%2.89M-43.53%579.79K-13.37%511.91K-10.44%848.58K119.15%945.86K21.83%3M98.06%1.03M29.03%590.88K
Research and development costs 276.45%339.01K-52.95%167.58K-52.25%1.1M-76.88%188.36K427.98%460.58K-88.22%90.06K-43.17%356.17K-52.19%2.29M493.11%814.69K-91.59%87.23K
Operating profit 19.52%-1M72.24%-521.97K12.92%-5.24M54.80%-985.85K-40.80%-1.13M32.06%-1.25M-56.56%-1.88M25.23%-6.02M-299.45%-2.18M52.21%-801.17K
Net non-operating interest income (expenses) 0.00%30842.86%4200.91%2.1K64.01%76133.45%734-48.58%308-36.77%294-82.58%2.08K-28.83%464-75.79%550
Non-operating interest income 0.00%30842.86%4200.91%2.1K64.01%76133.45%734-48.58%308-36.77%294-82.58%2.08K-28.83%464-75.79%550
Other net income (expenses) -4,125.19%-1.54M-111.96%-36.48K
Special income (charges) ---------4,125.19%-1.54M-------------------36.48K--------
-Less:Impairment of capital assets --------4,125.19%1.54M------------------36.48K--------
Income before tax 19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K
Income tax
Earnings from equity interest net of tax
Net income 19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K
Net income continuous operations 19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K
Noncontrolling interests
Net income attributable to the company 19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M52.17%-800.62K
Diluted earnings per share 61.54%-0.0585.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13-32.62%-0.216.43%-0.87-4,514.89%-0.2943.28%-0.12
Basic earnings per share 61.54%-0.0585.00%-0.0348.28%-0.4544.78%-0.160116.67%-0.151.85%-0.13-32.62%-0.216.43%-0.87-4,514.89%-0.2943.28%-0.12
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg